Home > News > Gene technology moves forward at Mirus Bio
July 30th, 2007
Gene technology moves forward at Mirus Bio
Mirus later developed two methods for delivery intravenously via the veins, similar to administering an IV. Such a procedure can be done in 10 to 15 minutes, and is similar to giving blood, except that the material goes into the body rather than being withdrawn.
The first, "hydrodynamic intravascular injection," involves pressurized delivery of nucleic acids through the bloodstream to surrounding cells and tissues. This enables regional delivery to a limb or other targeted area of the body.
The second delivery platform involves nanoparticle formulations that are delivered via a standard IV injection -- no pressure is involved -- and can be targeted to specific tissues and cells without being limited to the area of injection.
Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014
The Pocket Project will develop a low-cost and accurate point-of-care test to diagnose Tuberculosis: ICN2 holds a follow-up meeting of the Project on September 18th - 19th September 18th, 2014
New non-invasive technique could revolutionize the imaging of metastatic cancer September 17th, 2014
Recruiting bacteria to be technology innovation partners: September 17th, 2014
Iranian Scientists Separate Zinc Ion at Low Concentrations September 20th, 2014
Iranian Researchers Synthesize Stable Ceramic Nanopowders at Room Temperature September 20th, 2014
Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014
New research points to graphene as a flexible, low-cost touchscreen solution September 19th, 2014